explore -WSS

explore

author：fashion 2025-09-28 18:57:25 - browse：76377

Blue CAR-T cell attacks a leukemia cell. --health coverage from STAT — Engineered receptors on the surface of a T-lymphocyte bind to a leukemia cell. Adobe

The announcement on Tuesday that the Food and Drug Administration was investigating whether CAR-T immunotherapy had itself caused blood cancers initially appeared to be a significant blow to one of the brightest spots in cancer care.

But experts quickly cautioned that risk of this complication is probably minuscule compared to the known risk of secondary cancers from other cancer therapies like chemotherapy and radiation. They noted that CAR-T cells are immune cells that are genetically engineered to fight cancer, and that such genetic modifications were long thought to carry a risk of causing a second, new cancer in patients. The surprise, in a way, is that since CAR-T was first invented more than 10 years ago, that risk had remained just theoretical.

“There’s been a requirement for long-term follow up. I think this is why we’re all surprised. As far as I think any one of us knew, it’d never happened with any of the FDA-approved CAR-Ts,” said Marcela Maus, a cell therapy researcher at Mass General Cancer Center.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Asahi Kasei to buy Calliditas, picking up kidney disease drug

knowledge

WSS

Clinicians often fail to acknowledge the pain caused by long Covid

FDA advisers vote against ALS treatment from BrainStorm

Protect nursing home residents from future pandemics

Should insurance cover cosmetic surgery?

Clinicians often fail to acknowledge the pain caused by long Covid

Why we need mandatory labeling of GMO products

hotspot

explore

focus

Affirmative action in medical school literally saved lives

Kaiser Permanente unions announce official strike date

What does generative AI mean for health care? We asked experts

After a drawn out lobbying fight, ARPA

Peter Hotez and the public health issue of online harassment

Medicaid, Medicare dual

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Lawsuit challenges CMS nursing home minimum staffing rule

How to save PrEP access — and even expand it

Would Medicare drug price negotiations stall in a shutdown?

Wikipedia

Mindstrong's demise and the future of mental health care

STAT Virtual Event: How to Increase Diversity in Clinical Trials

Louisiana bill approved classifying abortion pills as controlled substances

Why do women spend more than men on medical expenses?

Guardant Health colon cancer test endorsed by FDA advisory panel

Why some fertility treatments produce more boy babies

hotspot

focus

knowledge

focus